AstraZeneca to acquire Ardea Biosciences
LONDON and SAN DIEGO — AstraZeneca plans to buy Ardea Biosciences Inc. in a cash deal valued at $1.26 billion.…
April 23, 2012 by Chain Drug Review Supplier News
LONDON and SAN DIEGO — AstraZeneca plans to buy Ardea Biosciences Inc. in a cash deal valued at $1.26 billion.…
April 23, 2012 by Chain Drug Review Supplier News
NEW YORK — Pfizer has unveiled a deal to sell its pediatric nutrition business to Nestle for $11.85 billion in…
April 23, 2012 by Chain Drug Review Supplier News
PARSIPPANY, N.J. — Watson Pharmaceuticals Inc. has launched an authorized generic version of Fortamet, a treatment for type 2 diabetes.…
April 20, 2012 by Chain Drug Review Supplier News
WOODCLIFF LAKE, N.J. — Par Pharmaceutical Cos. has agreed to acquire the U.S. rights to market and distribute a generic…
April 20, 2012 by Chain Drug Review Supplier News
NEW YORK — La Roche-Posay is highlighting its array of products formulated for sensitive skin during Rosacea Awareness Month in…
April 19, 2012 by Chain Drug Review Supplier News
LADY LAKE, Fla. — Dr. Neuzil’s Irrigator nasal cleansing spray has been added to the distribution channel of the Chain…
April 19, 2012 by Chain Drug Review Supplier News
ARMONK, N.Y. — IBM Corp. plans to sell its IBM Retail Store Solutions (RSS) business to Toshiba TEC Corp. for…
April 19, 2012 by Chain Drug Review Supplier News
ST. PAUL, Minn. — 3M has introduced Scotch Greener Masking Tapes, designed to provide the same reliable performance as other…